146 related articles for article (PubMed ID: 1383625)
21. Changes in hemodynamic parameters, inotropic state, and myocardial oxygen consumption owing to intravenous application of nitroglycerin.
Hempelmann G; Piepenbrock S; Seitz W; Karliczek G
J Thorac Cardiovasc Surg; 1977 Jun; 73(6):836-47. PubMed ID: 404479
[TBL] [Abstract][Full Text] [Related]
22. Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.
Paulson DJ; Traxler J; Schmidt M; Noonan J; Shug AL
Cardiovasc Res; 1986 Jul; 20(7):536-41. PubMed ID: 3779750
[TBL] [Abstract][Full Text] [Related]
23. L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge.
Sassen LM; Bezstarosti K; Van der Giessen WJ; Lamers JM; Verdouw PD
Am J Physiol; 1991 Jul; 261(1 Pt 2):H172-80. PubMed ID: 1858918
[TBL] [Abstract][Full Text] [Related]
24. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Lagioia R; Scrutinio D; Mangini SG; Ricci A; Mastropasqua F; Valentini G; Ramunni G; Totaro Fila G; Rizzon P
Int J Cardiol; 1992 Feb; 34(2):167-72. PubMed ID: 1737667
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.
Remme WJ; Krauss XH; van Hoogenhuyze DC; Kruyssen DA
J Am Coll Cardiol; 1993 Mar; 21(3):709-20. PubMed ID: 8436753
[TBL] [Abstract][Full Text] [Related]
26. Preservation of left ventricular performance with reduced ischemic dysfunction by intravenous nisoldipine.
Kimball BP; Watson KR; Bui S; Frankel D
Am J Cardiol; 1990 Aug; 66(4):400-5. PubMed ID: 2386114
[TBL] [Abstract][Full Text] [Related]
27. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction.
Pfisterer M; Burkart F; Müller-Brand J; Kiowski W
J Am Coll Cardiol; 1985 May; 5(5):1205-11. PubMed ID: 3989133
[TBL] [Abstract][Full Text] [Related]
28. Controlled study on L-carnitine therapeutic efficacy in post-infarction.
Davini P; Bigalli A; Lamanna F; Boem A
Drugs Exp Clin Res; 1992; 18(8):355-65. PubMed ID: 1292918
[TBL] [Abstract][Full Text] [Related]
29. Improvement of cardiac function in thalassemia major treated with L-carnitine.
El-Beshlawy A; Ragab L; Fattah AA; Ibrahim IY; Hamdy M; Makhlouf A; Aoun E; Hoffbrand V; Taher A
Acta Haematol; 2004; 111(3):143-8. PubMed ID: 15034235
[TBL] [Abstract][Full Text] [Related]
30. L-propionylcarnitine and myocardial performance in stunned porcine myocardium.
Sassen LM; Duncker DJ; Hogendoorn A; McFalls EO; Krams R; Bezstarosti K; Lamers JM; Verdouw PD
Mol Cell Biochem; 1992 Oct; 116(1-2):147-53. PubMed ID: 1480143
[TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
[TBL] [Abstract][Full Text] [Related]
32. Antianginal effects of nitroglycerin during exercise-induced angina: hemodynamic and left ventricular function changes related to indexes of myocardial oxygen consumption.
Choong CY; Roubin GS; Bautovich GJ; Harris PJ; Kelly DT
Am J Cardiol; 1987 Nov; 60(15):10H-14H. PubMed ID: 3120560
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of serial radionuclide monitoring during graded nitroglycerin infusion for unstable angina pectoris for determining left ventricular function and individualized therapeutic dose.
Breisblatt WM; Vita NA; Armuchastegui M; Cohen LS; Zaret BL
Am J Cardiol; 1988 Apr; 61(10):685-90. PubMed ID: 3128097
[TBL] [Abstract][Full Text] [Related]
34. Variable response to atrial pacing after intravenous propranolol in patients with stable exertional angina.
De Servi S; Ferrario M; Ghio S; Cioffi P; Angoli L; Bramucci E; Aimè E; Montericcio V; Specchia G
Eur Heart J; 1990 Nov; 11(11):997-1005. PubMed ID: 2282930
[TBL] [Abstract][Full Text] [Related]
35. Carnitine and left ventricular function in haemodialysis patients.
Fagher B; Cederblad G; Monti M; Olsson L; Rasmussen B; Thysell H
Scand J Clin Lab Invest; 1985 May; 45(3):193-8. PubMed ID: 3890132
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.
Chiddo A; Gaglione A; Musci S; Troito G; Grimaldi N; Locuratolo N; Rizzon P
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():107-11. PubMed ID: 2031868
[TBL] [Abstract][Full Text] [Related]
37. [The anti-angina action of carnitine].
Cherchi A; Fonzo R; Lai C; Mercuro G; Corsi M
Boll Soc Ital Cardiol; 1978; 23(1):71-89. PubMed ID: 754784
[No Abstract] [Full Text] [Related]
38. [Comparative evaluation of the effects of carnitine stereoisomers and racemate on the cardio- and hemodynamics of rats on a carnitine-deficient diet].
Spasov AA; Iezhitsa IN; Tiurenkov IN; Perfilova VN; Gurova NA; Kravchenko MS
Vestn Ross Akad Med Nauk; 2006; (7):20-7. PubMed ID: 16924874
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
Thormann J; Kramer W; Schlepper M
Am Heart J; 1982 Dec; 104(6):1294-302. PubMed ID: 7148647
[TBL] [Abstract][Full Text] [Related]
40. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH
Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
